Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2023-03-17 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
The USFDA conducted Pre-Approval Inspection [PAI] of our Oral-Oncology manufacturing facility at Bileshwarpura, Gujarat from 13-Mar-23 to 17-Mar-23. At the end of the inspection, we ....
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to the stock exchanges (BSE and NSE) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about a USFDA Pre-Approval Inspection and the issuance of a Form 483 with one procedural observation. The document is an intimation or announcement of an event related to regulatory compliance and inspection results. It does not contain financial data, detailed reports, or management discussion. The length is only 1508 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-03-17 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) regarding a newspaper advertisement about the Notice of Hearing of a Petition related to a Scheme of Arrangement (Amalgamation) between Curatio Health Care (I) Private Limited and Torrent Pharmaceuticals Limited. It references a regulatory requirement under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and informs about the date fixed for the hearing before the National Company Law Tribunal. The document is short (1966 characters) and serves as an announcement of a legal proceeding notice publication rather than the legal proceeding report itself. It does not contain financial data, management discussion, or detailed report content. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-03-16 English
Newspaper advertisement in respect of Notice of Hearing of Petition Ref : Scheme of Arrangement in the nature of Amalgamation of Curatio Health Care (I) Private Limited with Torrent ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) regarding a newspaper advertisement about the Notice of Hearing of a Petition related to a Scheme of Arrangement (Amalgamation) involving Torrent Pharmaceuticals Limited. It references a regulatory requirement under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and encloses a copy of the notice published in newspapers. The document is short (1966 characters) and serves as an announcement of a legal proceeding notice publication rather than the actual legal proceeding report or merger filing. It does not contain financial data, management discussion, or detailed merger documentation. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-03-16 English
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a short letter dated 18th February 2023 addressed to the stock exchanges (BSE and NSE) regarding the intimation of the schedule of an investors meet, specifically participation in Kotak's Investors Conference on 23rd February 2023. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document is brief (1364 characters) and serves as a notification of an upcoming investor event rather than a detailed report or financial statement. It does not contain financial data, audit information, voting results, or management changes. It is an announcement of an investor meeting schedule, which fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-02-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short letter dated 18th February 2023 addressed to the BSE Limited listing department. It informs about the schedule of an investor meet, specifically participation in Kotak's Investors Conference on 23rd February 2023. The letter references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document does not contain any financial data, report content, or detailed presentation materials. It is essentially an announcement or intimation about an upcoming investor event. Given the short length (1364 characters) and the nature of the content (intimation of schedule of investors meet), this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-02-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short letter dated 15th February 2023 addressed to the BSE Limited listing department. It informs about the schedule of an investor meet (IIFL’s 14th Enterprising India Global Investors’ Conference on 16th February 2023) and requests the exchange to take note of this information. The document references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document is brief (1394 characters) and does not contain any financial data, results, or detailed report content. It is an announcement of an event (investor meeting) rather than a report or detailed presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-02-15 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.